IQMD
NASDAQIntelligent Medicine Acquisition Corp.
Latest news
25 items- 13D/GSEC Form SC 13G filed by Intelligent Medicine Acquisition Corp.SC 13G - Intelligent Medicine Acquisition Corp. (0001850051) (Subject)
- SECSEC Form 15-12G filed by Intelligent Medicine Acquisition Corp.15-12G - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)
- SECSEC Form 25-NSE filed by Intelligent Medicine Acquisition Corp.25-NSE - Intelligent Medicine Acquisition Corp. (0001850051) (Subject)
- INSIDERSEC Form 3: New insider Goldman Sachs Group Inc claimed ownership of 200,000 shares3 - Intelligent Medicine Acquisition Corp. (0001850051) (Issuer)
- SECIntelligent Medicine Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)
- NEWSIntelligent Medicine Acquisition Corp. Announces It Will Redeem Its Public Shares
- PRIntelligent Medicine Acquisition Corp. Announces It Will Redeem Its Public SharesIntelligent Medicine Acquisition Corp. (NASDAQ:IQMD) (the "Company"), a blank-check company formed for the purpose of acquiring or merging with one or more businesses, today announced that because the Company does not believe it will be able to consummate an initial business combination within the time period required by its Amended and Restated Certificate of Incorporation (the "Charter"), the Company intends to dissolve and liquidate in accordance with the provisions of the Charter, and will redeem all of the outstanding shares of Class A common stock that were included in the units issued in its initial public offering (the "Public Shares"), at a per-share redemption price of approximate
- SECSEC Form 10-K filed by Intelligent Medicine Acquisition Corp.10-K - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)
- 13D/GSEC Form SC 13G/A filed by Intelligent Medicine Acquisition Corp. (Amendment)SC 13G/A - Intelligent Medicine Acquisition Corp. (0001850051) (Subject)
- SECIntelligent Medicine Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)
- SECIntelligent Medicine Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)
- SECSEC Form NT 10-K filed by Intelligent Medicine Acquisition Corp.NT 10-K - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)
- INSIDERSEC Form 4: Saba Capital Management, L.P. returned $22,443,808 worth of shares to the company (2,170,581 units at $10.34)4 - Intelligent Medicine Acquisition Corp. (0001850051) (Issuer)
- 13D/GSEC Form SC 13D filed by Intelligent Medicine Acquisition Corp.SC 13D - Intelligent Medicine Acquisition Corp. (0001850051) (Subject)
- INSIDERSEC Form 4 filed by Intelligent Medicine Sponsor Llc4 - Intelligent Medicine Acquisition Corp. (0001850051) (Issuer)
- SECIntelligent Medicine Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits8-K - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)
- SECSEC Form DEFA14A filed by Intelligent Medicine Acquisition Corp.DEFA14A - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)
- SECIntelligent Medicine Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)
- PRIntelligent Medicine Acquisition Corp. Announces Adjournment of Special Meeting of StockholdersIntelligent Medicine Acquisition Corp. (NASDAQ:IQMD) (the "Company") announced today that it has postponed the Company's Special Meeting of Stockholders to be held on February 3, 2023, at 9:30 a.m. Eastern Time until February 8, 2023, at 9:30 a.m. Eastern Time. The postponed Special Meeting will be completely virtual, and stockholders will be able to attend the special meeting online, vote and submit questions by visiting https://www.cstproxy.com/iqmdspac/2023. There will be no change in the record date as a result of this postponement or the date by which stockholders must have elected to redeem their public shares, and proxies tendered prior to the postponed date will not need to be voted
- SECSEC Form DEFA14A filed by Intelligent Medicine Acquisition Corp.DEFA14A - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)
- SECSEC Form DEF 14A filed by Intelligent Medicine Acquisition Corp.DEF 14A - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)
- SECSEC Form PRE 14A filed by Intelligent Medicine Acquisition Corp.PRE 14A - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)
- SECSEC Form 10-Q filed by Intelligent Medicine Acquisition Corp.10-Q - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)
- SECSEC Form 10-Q filed by Intelligent Medicine Acquisition Corp.10-Q - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)
- PRKroll Appoints Patience Marime-Ball as Senior Advisor to Kroll's ESG Advisory ServicesKroll, the leading provider of data, technology and insights related to risk, governance and growth, announced today Patience Marime-Ball will be a Senior Advisor to Kroll's Environmental, Social and Governance (ESG) Advisory Services Committee. Kroll provides an extensive range of advisory support and technology solutions to address growing ESG challenges, create sustainable value and growth, and effectively manage risk. Marime-Ball will play a critical role advising Kroll and its clients on how to drive meaningful changes that will help benefit people and the planet. "We're excited to welcome Patience as a new Senior Advisor to Kroll on ESG," said Jake Silverman, Chief Executive Officer
IQMD FAQ
6 questionsWhat does Intelligent Medicine Acquisition Corp. do?
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.Where does IQMD stock trade?
Intelligent Medicine Acquisition Corp. (IQMD) is listed on NASDAQ.What sector and industry is IQMD in?
Intelligent Medicine Acquisition Corp. operates in the Industrials sector, Consumer Electronics/Appliances industry.When did Intelligent Medicine Acquisition Corp. go public?
Intelligent Medicine Acquisition Corp. (IQMD) completed its IPO in 2021.What companies are similar to IQMD?
Notable peers in the same industry include GE (GE Aerospace), SONY (Sony Group Corporation), EMR (Emerson Electric Company), OTIS (Otis Worldwide Corporation), SN (SharkNinja Inc.). Compare IQMD side-by-side with any of them on Quantisnow.How can I track IQMD on Quantisnow?
Quantisnow aggregates Intelligent Medicine Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IQMD to receive live email and push alerts on every new disclosure.